Polpharma Pharmaceutical Works - API Manufacturer

drukuj

Products   

Building new capabilities in Green Chemistry will enable Polpharma to support more sustainable growth, open new opportunities for investment in environmentally friendly technologies, and for employment, as well as to protect human health and natural resources in an effective way. In order to provide the best solutions for customers' needs, Polpharma is constantly modernizing its product portfolio and enriching it with new, attractive APIs with a non-infringing process.

 

API manufacturing is carried out in GMP-compliant and FDA-approved multipurpose plants.

 

 

The proven quality of our products is secured by:

  • Strict adherence to the cGMP regulations
  • State-of-the-art technology
  • Top class processes and analytical equipment
  • Quality risk assessment

Latest news

Successful GMP audit by Japanese companies

Thursday, 01-07-2010
Polpharma Fine Chemicals Business Unit passed successfully inspection by two of the major generic Japanese...

EU DMF for Solifenacin succinate available

Wednesday, 12-05-2010
EU DMF documentation in eCTD format for Solifenacin succinate manufactured by Polpharma Fine Chemicals...

Polpharma recognised for investing in research and development

Tuesday, 04-05-2010
Polpharma reached the top leaders of the ranking of the largest investors in research and development in...

Process Excellence Award

Wednesday, 28-04-2010
Polpharma was ranked among the first three companies in the “Green Process Award”, of the 11th...
Copyright © 2009 Polpharma S.A. All rights reserved.
Realizacja: Ideo Powered by : EditoCMS